![Jennifer K. Zimmons](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van Jennifer K. Zimmons
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
PROLUNG, INC. | Investor Relations Contact | - | - |
Loopbaan van Jennifer K. Zimmons
Eerdere bekende functies van Jennifer K. Zimmons
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
9 METERS BIOPHARMA, INC. | Investor Relations Contact | - | - |
Statistieken
Internationaal
Verenigde Staten | 3 |
Operationeel
Investor Relations Contact | 2 |
Sectoraal
Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
9 METERS BIOPHARMA, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
ProLung, Inc.
![]() ProLung, Inc. Medical SpecialtiesHealth Technology ProLung, Inc. is a medical technology company, which specializes in predictive analytics technology, early stage lung cancer risk testing. It develops, tests and commercializes solutions which are designed to accelerate the time to diagnosis and expand the therapeutic window for lung cancer patients. Its product under the name of ProLung Test was developed to assess the risk of malignancy in lung nodules found in the chest by a Computed Tomography scan. The company was founded by Steven C. Eror on November 19, 2004 and is headquartered in Salt Lake City, UT. | Health Technology |
- Beurs
- Insiders
- Jennifer K. Zimmons
- Ervaring